Boost vs Surgery: Breast Induration Risk

At ESTRO 2025, Kristine Wiborg Høgsbjerg, MD and PhD student at Aarhus University, presented a post hoc analysis from the Danish Breast Cancer Group’s HYPO and PBI trials. The study compares repeat surgery versus tumor bed boost and their individual impact on breast induration, highlighting the need for individualized decisions at multidisciplinary meetings.